CABALETTA BIO, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $118.0M | $122.2M |
| FY2022 | — | $104.5M | $81.6M |
| FY2023 | — | $236.2M | $193.2M |
| FY2024 | — | $152.3M | $164.0M |
| FY2025 | — | $112.1M | $83.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $118.0M | $122.2M |
| FY2022 | — | $104.5M | $81.6M |
| FY2023 | — | $236.2M | $193.2M |
| FY2024 | — | $152.3M | $164.0M |
| FY2025 | — | $112.1M | $83.0M |